Holdings
Versant Venture Management, LLC
As of Jun 30, 2026, Versant Venture Management, LLC reported 6 positions worth US$154M. Largest: Monte Rosa Therapeutics, Inc., Century Therapeutics, Inc. and Jade Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 3.18M | US$77M | no change | Jun 30, 2026 |
| Century Therapeutics, Inc. | 12.2M | US$29.8M | no change | Jun 30, 2026 |
| Jade Biosciences, Inc. | 992K | US$22M | −534K | Jun 30, 2026 |
| Lenz Therapeutics, Inc. | 2.66M | US$15.1M | no change | Jun 30, 2026 |
| Contineum Therapeutics, Inc. | 543K | US$8.89M | no change | Jun 30, 2026 |
| Skye Bioscience, Inc. | 2.01M | US$1.39M | no change | Jun 30, 2026 |